Literature DB >> 8862301

Interpretation of captopril transplant renography using a feed forward neural network.

D Hamilton1, U J Miola, D Mousa.   

Abstract

UNLABELLED: Severe renal artery stenosis (RAS) is a relatively uncommon complication after renal transplantation but is a curable cause of hypertension, which demands reliable early diagnosis to reduce morbidity, mortality and graft loss. Captopril renography has been used for a number of years as a method of detecting RAS but controversy still exists as to the diagnostic accuracy of this test and as to the most appropriate interpretation criteria with which to establish a positive result.
METHODS: This report presents the results of using artificial neural networks to impartially assess these interpretation criteria. Data comprised 31 99mTc-MAG3 captopril renography investigations undertaken on hypertensive renal transplant patients with a suspected diagnosis of RAS. Each renogram study was correlated with an arteriogram as the "gold standard". Training of the network was performed using the round-robin technique.
RESULTS: An accuracy of 95% could be achieved by considering perfusion index, time-to-peak activity, accumulation index and excretion index for both pre- and post-challenge studies. This varied as the parameters were either included or excluded.
CONCLUSION: Artificial neural network analysis is a useful technique to evaluate the most appropriate criteria for interpreting captopril transplant renography investigations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862301

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  2 in total

Review 1.  Computer-assisted diagnosis in renal nuclear medicine: rationale, methodology, and interpretative criteria for diuretic renography.

Authors:  Andrew T Taylor; Ernest V Garcia
Journal:  Semin Nucl Med       Date:  2014-03       Impact factor: 4.446

2.  Decision support systems in diuresis renography.

Authors:  Andrew Taylor; Amita Manatunga; Ernest V Garcia
Journal:  Semin Nucl Med       Date:  2008-01       Impact factor: 4.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.